scholarly journals Analysis of Pathology of RObotic NErve-sparing (PRONE) radical prostatectomy: Does quantification of excised nerve bundles correlate with degree of nerve-spare and functional outcomes?

2020 ◽  
Vol 19 ◽  
pp. e1781
Author(s):  
C. Verrill ◽  
R.J. Bryant ◽  
L. Davies ◽  
F.C. Hamdy ◽  
P. Sooriakumaran
2021 ◽  
Vol 108 (Supplement_6) ◽  
Author(s):  
A Nathan ◽  
A Rashid ◽  
S Shukla ◽  
A Sinha ◽  
S Sivathasan ◽  
...  

Abstract Aim To assess whether the timing of post-operative Phosphodiesterase Inhibitor (PDE5i) therapy after Robot Assisted Radical Prostatectomy (RARP) is associated with a change in early erectile function, continence, or safety outcomes. Method Data was prospectively collected from a single surgeon in one tertiary centre and retrospectively evaluated. 158 patients were treated with PDE5i therapy post RARP over a two-year period. Results There were no significant differences in pre-operative characteristics between the therapy groups. Patients that had bilateral nerve sparing had a mean drop in Erectile Function (EF) score by 5.4 compared to 8.8 in the unilateral group. Additionally, 34.9% of bilateral nerve sparing patients returned to baseline compared to 12.1% of unilateral. Drop in EF scores and percentage return to baseline for unilateral nerve sparing was respectively 9 and 11.1% of immediate (day 1-2), 7 and 14.8% of early (day 3-14) and 9.7 and 9.5% of late (day >14) therapy (p = 0.9 and p = 0.6). For bilateral nerve sparing this was respectively 3.5 and 42.9% immediate therapy, 5.5 and 35.5% early therapy and 7.3 and 25% late therapy (p = 0.017 and p = 0.045). Pad free and social continence was achieved in 54% and 37% of those receiving immediate therapy, 60% and 33% for early therapy and 26% and 54% for late therapy. There were no differences in compliance, complication, or readmission outcomes. Conclusions Immediate PDE5i therapy should be considered in patients following nerve sparing RARP in order to maximise functional outcomes, especially in those undergoing bilateral nerve spare.


2019 ◽  
Vol 53 (6) ◽  
pp. 385-391 ◽  
Author(s):  
Sophie D. Fosså ◽  
Burkhard Beyer ◽  
Alv A. Dahl ◽  
Kirsti Aas ◽  
Lars Magne Eri ◽  
...  

2020 ◽  
Vol 19 ◽  
pp. e1112-e1113
Author(s):  
Y. Mitsui ◽  
T. Sadahira ◽  
Y. Maruyama ◽  
M. Araki ◽  
Y. Kobayashi ◽  
...  

2012 ◽  
Vol 62 (1) ◽  
pp. 42-52 ◽  
Author(s):  
Firas Abdollah ◽  
Maxine Sun ◽  
Nazareno Suardi ◽  
Andrea Gallina ◽  
Marco Bianchi ◽  
...  

2020 ◽  
Vol 8 (2) ◽  
pp. 43-49
Author(s):  
E. A. Sokolov ◽  
E. I. Veliev

Introduction. According to several studies, an increased body mass index (BMI) may be one of the unfavorable prognostic factors of prostate cancer (PC) associated with lower oncological and functional outcomes of radical prostatectomy (RP).Purpose of the study. To evaluate pathomorphological characteristics, recurrence-free survival, and restoration of erectile function (EF) after RP with nerve-sparing technique (NST) in obese patients.Materials and methods. The study group consisted of 91 patients with BMI ≥ 30 kg/m2 , the control group consisted of 356 patients with BMI < 30 kg/m2 who underwent RP with unilateral or bilateral NST from January 2012 to December 2019. A comparative analysis of pathomorphological results, the rate of complications, recurrence-free survival, and the dynamics of EF restoration in both groups was performed.Results. Obese patients had a larger prostate volume, a higher score for the International Prostate Symptom Score (IPSS) questionnaire. Unilateral and bilateral NST was used in both groups in equal proportions: 50.5% and 49.5% in the group with BMI ≥ 30 and 51.4% and 48.6% in the group with BMI < 30 (p = 0.88 ) There were no significant differences between the groups in the rate of adverse pathomorphological characteristics, serious postoperative complications and the volume of intraoperative blood loss. The five-year recurrence-free survival after RP was 93.1% in the BMI group ≥ 30 and 95.1% in the BMI group < 30 (p = 0.55). The total rate of EF recovery after RP with NST after 24 months was 75% and 78.5% (p = 0.24). The restoration of EF in obese patients was slower: sufficient for sexual intercourse EF after 6 and 12 months was observed in 17.9% and 32.1% versus 35.4% and 53.8% in the group with BMI < 30, and the meantime to recovery was 10.9 (± 1) and 8.6 (± 0.6) months, respectively (p = 0.04).Conclusions. Obesity does not affect the pathomorphological and oncological results of RP with NST. EF recovery in patients with a BMI of ≥ 30 is slowed down, however, 24 months after surgery, the results are comparable with the potency level in patients with a BMI < 30. The data obtained may be of value in counselling and planning surgical intervention in obese patients with PC.


2010 ◽  
Vol 106 (4) ◽  
pp. 543-547 ◽  
Author(s):  
Francesco Greco ◽  
Sigrid Wagner ◽  
M. Raschid Hoda ◽  
Felix Kawan ◽  
Antonino Inferrera ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document